Dissemin is shutting down on January 1st, 2025

Published in

Beilstein-Institut, Beilstein Journal of Organic Chemistry, (17), p. 1001-1040, 2021

DOI: 10.3762/bjoc.17.82

Links

Tools

Export citation

Search in Google Scholar

Synthetic accesses to biguanide compounds

Journal article published in 2021 by Oleksandr Grytsai, Cyril Ronco ORCID, Rachid Benhida
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Orange circle
Preprint: archiving restricted
Orange circle
Postprint: archiving restricted
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Biguanide is a unique chemical function, which has attracted much attention a century ago and is showing resurgent interest in recent years after a long period of dormancy. This class of compounds has found broad applications such as reaction catalysts, organic strong bases, ligands for metal complexation, or versatile starting materials in organic synthesis for the preparation of nitrogen-containing heterocycles. Moreover, biguanides demonstrate a wide range of biological activities and some representatives are worldwide known such as metformin, the first-line treatment against type II diabetes, or chlorhexidine, the gold standard disinfectant and antiseptic. Although scarcely represented, the number of “success stories” with biguanide-containing compounds highlights their value and their unexploited potential as future drugs in various therapeutic fields or as efficient metal ligands. This review provides an extensive and critical overview of the synthetic accesses to biguanide compounds, as well as their comparative advantages and limitations. It also underlines the need of developing new synthetic methodologies to reach a wider variety of biguanides and to overcome the underrepresentation of these compounds.